The analysis revealed significant differences in XRCC1 expression among different immune subtypes in multiple cancer types, including BLCA, BRCA, COAD, ESCA, HNSC, KIRC, LGG, LIHC, LUAD, PAAD, PCPG, PRAD, SARC, STAD, TGCT, and UCS (Figure 9). Here, XRCC1 is linked to cancer.